Nucleic acid structure containing a pyripyropene biosynthesis gene cluster and a marker gene

Details for Australian Patent Application No. 2011210968 (hide)

Owner Meiji Seika Pharma Co., Ltd.

Inventors Aihara, Sato; Sumida, Naomi; Murashima, Koichiro; Yanai, Kouji; Anzai, Hiroyuki; Yamamoto, Kentaro

Agent Davies Collison Cave

Pub. Number AU-A-2011210968

PCT Pub. Number WO2011/093186

Priority 2010-014700 26.01.10 JP; 2010-253183 11.11.10 JP

Filing date 19 January 2011

Wipo publication date 4 August 2011

International Classifications

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12P 17/18 Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/093186 Priority application(s): WO2011/093186

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011210969-Method for producing pyripyropene derivative by enzymatic process

2011210967-Method for manufacturing a pyripyropene